DOVITINIB: 38 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
38
Total FAERS Reports
8 (21.1%)
Deaths Reported
14
Hospitalizations
38
As Primary/Secondary Suspect
3
Life-Threatening
Active Ingredient: DOVITINIB LACTATE ·
First Report: 20120829 · Latest Report: 20150222
What Are the Most Common DOVITINIB Side Effects?
#1 Most Reported
Neutropenia
7 reports (18.4%)
#2 Most Reported
Fatigue
6 reports (15.8%)
#3 Most Reported
Drug interaction
6 reports (15.8%)
All DOVITINIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 7 | 18.4% | 0 | 3 |
| Deep vein thrombosis | 6 | 15.8% | 1 | 5 |
| Drug interaction | 6 | 15.8% | 0 | 0 |
| Fatigue | 6 | 15.8% | 0 | 3 |
| Pulmonary embolism | 5 | 13.2% | 2 | 2 |
Who Reports DOVITINIB Side Effects? Age & Gender Data
Gender: 50.0% female, 50.0% male. Average age: 56.8 years. Most reports from: US. View detailed demographics →
Is DOVITINIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 3 | 1 | 3 |
| 2013 | 3 | 0 | 2 |
| 2014 | 4 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
What Is DOVITINIB Used For?
| Indication | Reports |
|---|---|
| Neoplasm | 15 |
| Lung neoplasm malignant | 5 |
Official FDA Label for DOVITINIB
Official prescribing information from the FDA-approved drug label.